NEW YORK (TheStreet) -- CHANGE IN RATINGS
ARRIS Group (ARRS) was upgraded at Jefferies to buy from hold. Company will benefit from growth in set-top box replacement cycle, growth in the CMTS/CCAP business, and share gain vs. Cisco, Jefferies said. $30 price target.
Carnival (CCL) was upgraded at Credit Suisse to outperform from neutral. $43 price target. Estimates were also raised, as the new CEO appears to be turning the business around, Credit Suisse said.
Carnival was upgraded at UBS to buy from neutral. Higher conviction in forward outlook, especially from Costa brand, UBS said. $41 price target.
Meta Financial (CASH) was downgraded to hold at TheStreet Ratings.
IAC/InterActiveCorp (IACI) was downgraded at Wells Fargo to market perform. Company is experiencing a management shakeup and the outlook remains cautious for the search business, Wells Fargo said.
Lululemon (LULU) was initiated with a buy rating at Topeka Capital. $70 price target. Company remains the bright spot of growth in the industry, Topeka said.
3M (MMM) was upgraded at J.P. Morgan to neutral from underweight. $128 price target. Company is being more aggressive with its balance sheet, J.P. Morgan said.
Owens-Illinois (OI) was upgraded to buy at TheStreet Ratings.
Red Hat (RHT) was upgraded at UBS to buy from neutral. Cross-selling fueled billings with strengthening fundamentals, UBS said. $58 price target.
Royal Caribbean (RCL) was upgraded at UBS to buy from neutral. Valuation call, UBS said. $40 price target.
Red Robin (RRGB) was upgraded at Miller Tabak to buy from hold. $86 price target. Recent checks suggest that same-store sales growth should remain solid, Miller Tabak said.
Tibco Software (TIBX) was downgraded at UBS to neutral from buy. Pressure to get back to double-digit total license growth with lack of improved execution, UBS said.
Twitter (TWTR) was initiated with a market perform rating at BMO Capital. Valuation call, based on a $55 price target, BMO Capital said.
Stock Comments / EPS Changes
Accenture (ACN) estimates, target were boosted at BMO Capital. Shares are now seen reaching $82. Estimates were also increased, as the company is seeing higher booking and should benefit from M&A activity, BMO Capital said. Market Perform rating.
Accenture price target, EPS estimates were increased at Jefferies. Accenture raised its own numbers, Jefferies said. Based on F1Q14 results, revised forward numbers. $75 price target and hold rating.
Allergan (AGN) price target was increased at UBS. Driven by new patents for Restasis, UBS said. $116 price target and buy rating.
Sotheby's (BID) estimates, price target were increased at Wedbush. Estimates were increased through 2014. $60 price target. Company is realizing higher auction results, Wedbush said. Outperform rating.
Conagra (CAG) estimates, price target were raised at Credit Suisse. Shares are now seen reaching $35. Estimates were also increased, as management is improving its merchandising, Credit Suisse said. Neutral rating.
Darden Restaurants (DRI) price target, EPS estimates were lowered at Jefferies. Darden is decreasing its own numbers, Jefferies said. Despite spinoff of Red Lobster, there is a lack of evidence of turnaround strategy with weak fundamentals, Jefferies said. $47 price target and hold rating.
KB Home (KBH) price target, EPS estimates were increased at UBS. Rising home prices drive operating leverage, UBS said. $15 price target and sell rating.
Paychex (PAYX) estimates, price target were increased at BMO Capital. Estimates were boosted through 2015. Company remains leveraged to the positive macro environment, BMO Capital said. Market perform rating and new $43 price target.
TIBCO Software (TIBX) price target, EPS estimates were lowered at Jefferies. TIBX decreased its own numbers, Jefferies said. Soft BPM sales in EMEA, Jefferies also said. $27 price target and buy rating.
Follow TheStreet on Twitter and become a fan on Facebook.